Literature DB >> 30237293

The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium.

Thejaswi Kalagara1,2, Tracy Moutsis1, Yi Yang1,3, Karin I Pappelbaum1, Anne Farken1, Lucia Cladder-Micus2, Sabine Vidal-Y-Sy4, Axel John5, Alexander T Bauer4, Bruno M Moerschbacher2, Stefan W Schneider4, Christian Gorzelanny1,4.   

Abstract

The dynamic change from a globular conformation to an elongated fiber determines the ability of von Willebrand factor (VWF) to trap platelets. Fiber formation is favored by the anchorage of VWF to the endothelial cell surface, and VWF-platelet aggregates on the endothelium contribute to inflammation, infection, and tumor progression. Although P-selectin and ανβ3-integrins may bind VWF, their precise role is unclear, and additional binding partners have been proposed. In the present study, we evaluated whether the endothelial glycocalyx anchors VWF fibers to the endothelium. Using microfluidic experiments, we showed that stabilization of the endothelial glycocalyx by chitosan oligosaccharides or overexpression of syndecan-1 (SDC-1) significantly supports the binding of VWF fibers to endothelial cells. Heparinase-mediated degradation or impaired synthesis of heparan sulfate (HS), a major component of the endothelial glycocalyx, reduces VWF fiber-dependent platelet recruitment. Molecular interaction studies using flow cytometry and live-cell fluorescence microscopy provided further evidence that VWF binds to HS linked to SDC-1. In a murine melanoma model, we found that protection of the endothelial glycocalyx through the silencing of heparanase increases the number of VWF fibers attached to the wall of tumor blood vessels. In conclusion, we identified HS chains as a relevant binding factor for VWF fibers at the endothelial cell surface in vitro and in vivo.
© 2018 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30237293      PMCID: PMC6156889          DOI: 10.1182/bloodadvances.2017013995

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  61 in total

1.  Platelets, inflammatory cells, von Willebrand factor, syndecan-1, fibrin, fibronectin, and bacteria co-localize in the liver thrombi of Bacillus anthracis-infected mice.

Authors:  Taissia G Popova; Bryan Millis; Charles Bailey; Serguei G Popov
Journal:  Microb Pathog       Date:  2011-10-07       Impact factor: 3.738

Review 2.  The structure and function of the endothelial glycocalyx layer.

Authors:  Sheldon Weinbaum; John M Tarbell; Edward R Damiano
Journal:  Annu Rev Biomed Eng       Date:  2007       Impact factor: 9.590

3.  von Willebrand factor promotes leukocyte extravasation.

Authors:  Björn Petri; Andre Broermann; Hang Li; Alexander G Khandoga; Alexander Zarbock; Fritz Krombach; Tobias Goerge; Stefan W Schneider; Claire Jones; Bernhard Nieswandt; Martin K Wild; Dietmar Vestweber
Journal:  Blood       Date:  2010-08-17       Impact factor: 22.113

Review 4.  Unwinding the von Willebrand factor strings puzzle.

Authors:  Karen De Ceunynck; Simon F De Meyer; Karen Vanhoorelbeke
Journal:  Blood       Date:  2012-10-23       Impact factor: 22.113

5.  Shear-induced unfolding triggers adhesion of von Willebrand factor fibers.

Authors:  S W Schneider; S Nuschele; A Wixforth; C Gorzelanny; A Alexander-Katz; R R Netz; M F Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

6.  P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.

Authors:  Arnoldo Padilla; Joel L Moake; Aubrey Bernardo; Chalmette Ball; Yongtao Wang; Maneesh Arya; Leticia Nolasco; Nancy Turner; Michael C Berndt; Bahman Anvari; José A López; Jing-Fei Dong
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

Review 7.  von Willebrand factor and cancer: a renewed interest.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti; Giuseppe Lippi
Journal:  Thromb Res       Date:  2013-02-08       Impact factor: 3.944

8.  Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress.

Authors:  Karin I Pappelbaum; Christian Gorzelanny; Sandra Grässle; Jan Suckau; Matthias W Laschke; Markus Bischoff; Corinne Bauer; Marina Schorpp-Kistner; Christopher Weidenmaier; Reinhard Schneppenheim; Tobias Obser; Bhanu Sinha; Stefan W Schneider
Journal:  Circulation       Date:  2013-05-29       Impact factor: 29.690

9.  Heparins that block VEGF-A-mediated von Willebrand factor fiber generation are potent inhibitors of hematogenous but not lymphatic metastasis.

Authors:  Lukas Goertz; Stefan Werner Schneider; Anna Desch; Frank Thomas Mayer; Julian Koett; Kai Nowak; Ioannis Karampinis; Michael K Bohlmann; Viktor Umansky; Alexander Thomas Bauer
Journal:  Oncotarget       Date:  2016-10-18

10.  Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.

Authors:  DeannaLee M Beauvais; Brian J Ell; Andrea R McWhorter; Alan C Rapraeger
Journal:  J Exp Med       Date:  2009-03-02       Impact factor: 14.307

View more
  14 in total

Review 1.  Patrolling the vascular borders: platelets in immunity to infection and cancer.

Authors:  Florian Gaertner; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2019-08-13       Impact factor: 53.106

2.  A sticky proposition: The endothelial glycocalyx and von Willebrand factor.

Authors:  Seon Jae Choi; David Lillicrap
Journal:  J Thromb Haemost       Date:  2020-02-26       Impact factor: 5.824

Review 3.  Red Blood Cells: Chasing Interactions.

Authors:  Virginia Pretini; Mischa H Koenen; Lars Kaestner; Marcel H A M Fens; Raymond M Schiffelers; Marije Bartels; Richard Van Wijk
Journal:  Front Physiol       Date:  2019-07-31       Impact factor: 4.566

Review 4.  Platelets in Skin Autoimmune Diseases.

Authors:  Xiaobo Liu; Christian Gorzelanny; Stefan W Schneider
Journal:  Front Immunol       Date:  2019-07-04       Impact factor: 7.561

Review 5.  von Willebrand Factor and Platelet Glycoprotein Ib: A Thromboinflammatory Axis in Stroke.

Authors:  Frederik Denorme; Karen Vanhoorelbeke; Simon F De Meyer
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

Review 6.  Covid-19: The Rollercoaster of Fibrin(Ogen), D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes.

Authors:  Corlia Grobler; Siphosethu C Maphumulo; L Mireille Grobbelaar; Jhade C Bredenkamp; Gert J Laubscher; Petrus J Lourens; Janami Steenkamp; Douglas B Kell; Etheresia Pretorius
Journal:  Int J Mol Sci       Date:  2020-07-21       Impact factor: 5.923

7.  Bladder cancer-derived interleukin-1 converts the vascular endothelium into a pro-inflammatory and pro-coagulatory surface.

Authors:  A John; C Günes; C Bolenz; S Vidal-Y-Sy; A T Bauer; S W Schneider; C Gorzelanny
Journal:  BMC Cancer       Date:  2020-12-02       Impact factor: 4.430

8.  Roles of Endovascular Calyx Related Enzymes in Endothelial Dysfunction and Diabetic Vascular Complications.

Authors:  Zhi Li; Ning Wu; Jing Wang; Quanbin Zhang
Journal:  Front Pharmacol       Date:  2020-11-30       Impact factor: 5.810

Review 9.  Role of von Willebrand factor in venous thromboembolic disease.

Authors:  Alison Michels; David Lillicrap; Michael Yacob
Journal:  JVS Vasc Sci       Date:  2021-10-07

10.  ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium.

Authors:  Justine Münsterberg; Desirée Loreth; Laura Brylka; Stefan Werner; Jana Karbanova; Monja Gandrass; Svenja Schneegans; Katharina Besler; Fabienne Hamester; José Ramon Robador; Alexander Thomas Bauer; Stefan Werner Schneider; Michaela Wrage; Katrin Lamszus; Jakob Matschke; Yogesh Vashist; Güntac Uzunoglu; Stefan Steurer; Andrea Kristina Horst; Leticia Oliveira-Ferrer; Markus Glatzel; Thorsten Schinke; Denis Corbeil; Klaus Pantel; Cecile Maire; Harriet Wikman
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.